Why a Buyout Deal May Not Be in the Cards for Acadia Post author:Sam Post published:November 27, 2017 Post category:BioPharma A look at why a potential buyout of Acadia might not be as likely as some have suggested. Source: BioSpace You Might Also Like Gilead Commits $100M to Tackle the HIV/AIDS Epidemic in the Southern U.S. December 3, 2017 China Pharma Holdings Reports First Quarter 2017 Financial Results May 11, 2017 <b>Lexington Biosciences</b> Introduces President And Board Chair May 25, 2017